B1 Non-refereed article in a scientific journal

‘Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM’ – Author's reply




AuthorsBroman Niklas, Feuth Thijs, Oksi Jarmo; COVIDSTORM study group

PublisherElsevier B.V.

Publication year2022

JournalClinical Microbiology and Infection

Journal name in sourceClinical Microbiology and Infection

Journal acronymCLIN MICROBIOL INFEC

Volume28

Issue11

First page 1520

Last page1521

eISSN1469-0691

DOIhttps://doi.org/10.1016/j.cmi.2022.06.028

Web address https://doi.org/10.1016/j.cmi.2022.06.028

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/176385949



Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 16:31